| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.25 | 5e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.051 | 0.4 |